The U.S. Food and Drug Administration is preparing to authorize Pfizer-BioNTech COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency's plans.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3